RxDoctor Payments Data

Quirino Toledo, MD

Family Medicine · Jacksonville, FLNPI 1154399335

Payments from drug & device makers

$7,883in general payments, 2019–2025

Across 353 payments — averaging $22.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Boehringer Ingelheim$618
  • GSK$555
  • AbbVie$538
  • Pfizer$503
  • plus $3K from 34 others

What the payments were for

  • Consulting fees$50%
  • Food & beverage$7,859100%
  • Education$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,883 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$99,977
Medicare patients
238
Services billed
1,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide112$131,681
FarxigaDapagliflozin Propanediol96$104,527
EliquisApixaban110$84,012
JanuviaSitagliptin Phosphate78$71,530
JardianceEmpagliflozin68$57,255
MounjaroTirzepatide48$51,360
XareltoRivaroxaban49$41,148
Breo ElliptaFluticasone/Vilanterol37$17,294
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$16,771
JanumetSitagliptin Phos/Metformin Hcl23$15,205
Lantus SolostarInsulin Glargine,hum.Rec.Anlog49$9,475
Advair HfaFluticasone Propion/Salmeterol20$8,826
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$8,000
Atorvastatin Calcium541$6,727
Gabapentin394$5,144

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,404$131,681112 claims
AstraZenecaFarxiga$1,283$104,52796 claims
MerckJanuvia, Janumet$125$86,735101 claims
PfizerEliquis$503$84,012110 claims
Boehringer IngelheimJardiance$618$57,25568 claims
Lilly USA, LLCMounjaro$425$51,36048 claims
Johnson & JohnsonXarelto$494$41,14849 claims
GSKBreo Ellipta, Trelegy Ellipta$555$34,06562 claims
AbbVieSynthroid$538$2,73626 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →